PCIF1
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
Also known as: bA465L10.1, C20orf67, CAPAM, CAPAM_HUMAN, PPP1R121
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H4Z3
- Gene
- PCIF1
- Ensembl
- ENSG00000100982
- Chromosome
- 20
- Canonical length
- 704 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules,Cytokinetic bridge
OverviewNCBI Gene
Enables RNA polymerase II C-terminal domain phosphoserine binding activity; S-adenosyl-L-methionine binding activity; and mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity. Involved in mRNA processing; negative regulation of translation; and positive regulation of translation. Located in intercellular bridge; microtubule cytoskeleton; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
704 residues, UniProt reviewed canonical sequence.
>Q9H4Z3|PCIF1
1 MANENHGSPR EEASLLSHSP GTSNQSQPCS PKPIRLVQDL PEELVHAGWE KCWSRRENRP
61 YYFNRFTNQS LWEMPVLGQH DVISDPLGLN ATPLPQDSSL VETPPAENKP RKRQLSEEQP
121 SGNGVKKPKI EIPVTPTGQS VPSSPSIPGT PTLKMWGTSP EDKQQAALLR PTEVYWDLDI
181 QTNAVIKHRG PSEVLPPHPE VELLRSQLIL KLRQHYRELC QQREGIEPPR ESFNRWMLER
241 KVVDKGSDPL LPSNCEPVVS PSMFREIMND IPIRLSRIKF REEAKRLLFK YAEAARRLIE
301 SRSASPDSRK VVKWNVEDTF SWLRKDHSAS KEDYMDRLEH LRRQCGPHVS AAAKDSVEGI
361 CSKIYHISLE YVKRIREKHL AILKENNISE EVEAPEVEPR LVYCYPVRLA VSAPPMPSVE
421 MHMENNVVCI RYKGEMVKVS RNYFSKLWLL YRYSCIDDSA FERFLPRVWC LLRRYQMMFG
481 VGLYEGTGLQ GSLPVHVFEA LHRLFGVSFE CFASPLNCYF RQYCSAFPDT DGYFGSRGPC
541 LDFAPLSGSF EANPPFCEEL MDAMVSHFER LLESSPEPLS FIVFIPEWRE PPTPALTRME
601 QSRFKRHQLI LPAFEHEYRS GSQHICKKEE MHYKAVHNTA VLFLQNDPGF AKWAPTPERL
661 QELSAAYRQS GRSHSSGSSS SSSSEAKDRD SGREQGPSRE PHPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCIF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 43 nTPM
- ovary: 41 nTPM
- skeletal muscle: 41 nTPM
- endometrium: 40 nTPM
- blood vessel: 38 nTPM
- cervix: 37 nTPM
Single-cell type
- platelets: 51 nCPM
- esophageal apical cells: 47 nCPM
- cardiomyocytes: 40 nCPM
- neutrophils: 36 nCPM
- syncytiotrophoblasts: 35 nCPM
- melanocytes: 35 nCPM
Immune cell
- eosinophil: 80 nTPM
- basophil: 76 nTPM
- neutrophil: 75 nTPM
- NK-cell: 75 nTPM
- total PBMC: 64 nTPM
- naive B-cell: 56 nTPM
Brain region
- cerebellum: 48 nTPM
- white matter: 37 nTPM
- medulla oblongata: 34 nTPM
- basal ganglia: 33 nTPM
- pons: 32 nTPM
- cerebral cortex: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.41
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- RNA polymerase II C-terminal domain binding
- RNA polymerase II C-terminal domain phosphoserine binding
- S-adenosyl-L-methionine binding
- mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WW domain
- Heat shock protein 70kD, C-terminal domain superfamily
- WW domain superfamily
- WW domain
- PCIF1, WW domain
- mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase PCIF1-like
- Phosphorylated CTD interacting factor 1 WW domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCIF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCIF1 as an antibody target. Whether an autoantibody or antibody against PCIF1 could matter depends on whether native PCIF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCIF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCIF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...